(Q53912257)
Statements
Efficacy, safety, and adherence with a twice-daily combination lamivudine/zidovudine tablet formulation, plus a protease inhibitor, in HIV infection. (English)
Eron JJ
Yetzer ES
Ruane PJ
Becker S
Sawyer GA
Fisher RL
Tolson JM
Shaefer MS
1 April 2000
14
6
671-681